PL1937301T3 - Funkcjonalne cząsteczki podobne do wirusa grypy (VLP) - Google Patents

Funkcjonalne cząsteczki podobne do wirusa grypy (VLP)

Info

Publication number
PL1937301T3
PL1937301T3 PL06826264T PL06826264T PL1937301T3 PL 1937301 T3 PL1937301 T3 PL 1937301T3 PL 06826264 T PL06826264 T PL 06826264T PL 06826264 T PL06826264 T PL 06826264T PL 1937301 T3 PL1937301 T3 PL 1937301T3
Authority
PL
Poland
Prior art keywords
vlps
particles
influenza virus
functional influenza
functional
Prior art date
Application number
PL06826264T
Other languages
English (en)
Polish (pl)
Inventor
Gale Smith
Rick Bright
Peter Pushko
Jinyou Zhang
Kutub Mahmood
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of PL1937301T3 publication Critical patent/PL1937301T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
PL06826264T 2005-10-18 2006-10-18 Funkcjonalne cząsteczki podobne do wirusa grypy (VLP) PL1937301T3 (pl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US72751305P 2005-10-18 2005-10-18
US78084706P 2006-03-10 2006-03-10
US80000606P 2006-05-15 2006-05-15
US83119606P 2006-07-17 2006-07-17
US83211606P 2006-07-21 2006-07-21
US84549506P 2006-09-19 2006-09-19
EP20060826264 EP1937301B1 (en) 2005-10-18 2006-10-18 Functional influenza virus like particles (vlps)
PCT/US2006/040862 WO2007047831A2 (en) 2005-10-18 2006-10-18 Functional influenza virus like particles (vlps)

Publications (1)

Publication Number Publication Date
PL1937301T3 true PL1937301T3 (pl) 2015-10-30

Family

ID=37963272

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06826264T PL1937301T3 (pl) 2005-10-18 2006-10-18 Funkcjonalne cząsteczki podobne do wirusa grypy (VLP)

Country Status (19)

Country Link
EP (1) EP1937301B1 (enExample)
JP (5) JP5714799B2 (enExample)
KR (1) KR101359723B1 (enExample)
CN (2) CN103865892B (enExample)
AU (1) AU2006304640B2 (enExample)
BR (1) BRPI0617486A2 (enExample)
CA (1) CA2625406C (enExample)
DK (1) DK1937301T3 (enExample)
ES (1) ES2543056T3 (enExample)
HU (1) HUE026136T2 (enExample)
IL (1) IL190775A (enExample)
NZ (1) NZ567164A (enExample)
PL (1) PL1937301T3 (enExample)
PT (1) PT1937301E (enExample)
RU (1) RU2483751C2 (enExample)
SG (1) SG2014012868A (enExample)
SI (1) SI1937301T1 (enExample)
TW (1) TWI488968B (enExample)
WO (1) WO2007047831A2 (enExample)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0250488A (ja) * 1988-08-11 1990-02-20 Nec Corp 超伝導配線
US8551756B2 (en) 2003-07-11 2013-10-08 Novavax, Inc. Avian influenza chimeric VLPS
US8778353B2 (en) 2006-05-01 2014-07-15 Technovax, Inc. Influenza virus-like particle (VLP) compositions
US9101578B2 (en) 2006-05-01 2015-08-11 Technovax, Inc. Polyvalent influenza virus-like particle (VLP) compositions
AU2007345768B2 (en) * 2006-07-27 2013-08-01 Ligocyte Pharmaceuticals, Inc. Chimeric influenza virus-like particles
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
AU2009202819B2 (en) 2007-07-13 2014-08-28 Aramis Biotechnologies Inc. Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
EP2175883A4 (en) * 2007-07-19 2011-11-30 Novavax Inc CHIMERIC VARICELLA ZOSTER VIRUS-VIRUSUAL PARTICLES
AU2008331673B2 (en) 2007-11-12 2014-12-11 The Trustees Of The University Of Pennsylvania Novel vaccines against multiple subtypes of influenza virus
EP2294202B1 (en) 2008-07-08 2015-05-20 Medicago Inc. Soluble recombinant influenza antigens
PT2318530T (pt) * 2008-07-18 2016-09-30 Medicago Inc Novo epítopo de imunização contra o vírus da gripe
EP2367566B2 (en) * 2008-11-28 2019-11-27 Boehringer Ingelheim Animal Health USA Inc. Recombinant avian influenza vaccine and uses thereof
US20120263743A1 (en) * 2009-04-30 2012-10-18 Cytos Biotechnology Ag Influenza hemagglutinin compositions and uses thereof
NZ595710A (en) * 2009-05-01 2013-10-25 Redbiotec Ag Recombinant virus-like particles encoded by multi-gene vector
TW201738562A (zh) * 2009-05-28 2017-11-01 亞培生物股份有限公司 體外病原體檢驗技術
CN102482328B (zh) 2009-06-24 2014-11-26 麦迪卡格公司 包含血凝素的嵌合流感病毒样颗粒
SI2480560T1 (en) 2009-09-22 2018-04-30 Medicago Inc. A process for preparing proteins derived from plants
US9352031B2 (en) * 2010-02-18 2016-05-31 Technovax, Inc. Universal virus-like particle (VLP) influenza vaccines
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
JP2012036154A (ja) * 2010-08-11 2012-02-23 Goshu Yakuhin Kk 食品
CN101947317B (zh) * 2010-09-27 2012-05-30 武汉大学 一种h5n1禽流感病毒样颗粒疫苗的规模化制备方法
US20140004146A1 (en) * 2011-03-17 2014-01-02 Institut Pasteur Of Shanghai, Chinese Academy Of Sciences Method for producing virus-like particle by using drosophila cell and applications thereof
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
EA016866B1 (ru) * 2011-06-06 2012-08-30 Общество С Ограниченной Ответственностью "Форт" (Ооо "Форт") Вакцина для специфической профилактики гриппа
KR101302245B1 (ko) * 2011-06-27 2013-09-02 조지아 스테이트 유니버시티 리서치 파운데이션, 인코포레이티드 넓은 범위의 교차 방어능력을 갖는 신규한 보강 인플루엔자 백신
AR088028A1 (es) * 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal
JP2014527799A (ja) 2011-08-26 2014-10-23 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
JP5884100B2 (ja) * 2011-08-31 2016-03-15 公益財団法人東京都医学総合研究所 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有するＤＩｓ株由来組換えワクシニアウイルス
CA2850407C (en) * 2011-09-30 2021-11-23 Medicago Inc. Increasing virus-like particle yield in plants
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
EP3520809B1 (en) * 2012-02-03 2025-08-06 Emory University Immunostimulatory compositions.
RU2485973C1 (ru) * 2012-02-28 2013-06-27 Общество с ограниченной ответственностью "НТфарма" Рекомбинантная трехвалентная вакцина от гриппа человека
ES2689878T3 (es) * 2013-02-21 2018-11-16 Boehringer Ingelheim Vetmedica Gmbh Proteínas H5 del virus de la gripe H5N1 para su uso como un medicamento
US9649375B2 (en) * 2013-03-14 2017-05-16 The Administrators Of The Tulane Educational Fund Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith
JP2016516415A (ja) 2013-03-28 2016-06-09 メディカゴ インコーポレイテッド 植物におけるインフルエンザウイルス様粒子の生成
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
DK3092309T3 (da) 2014-01-10 2021-04-12 Medicago Inc Cpmv-forstærkerelementer
CN103740655A (zh) * 2014-01-20 2014-04-23 瑞鑫百奥生物科技（深圳）有限公司 H5n1禽流感病毒样颗粒及其应用和制备方法、疫苗
WO2015143567A1 (en) 2014-03-27 2015-10-01 Medicago Inc. Modified cpmv enhancer elements
WO2015195218A1 (en) * 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Polyvalent influenza virus-like particles (vlps) and use as vaccines
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
US10494613B2 (en) * 2015-08-28 2019-12-03 Wisconsin Alumni Research Foundation (Warf) Generation of infectious influenza viruses from virus-like particles
RU2639491C2 (ru) * 2015-08-31 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Вирионы и вирусоподобные частицы вируса мозаики альтернантеры как усилители иммунного ответа
US10426829B2 (en) 2015-09-03 2019-10-01 Novavax, Inc. Vaccine compositions having improved stability and immunogenicity
US11197925B2 (en) 2016-02-19 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development
EP3445398A4 (en) * 2016-04-18 2020-04-01 Emerging Viral Vaccine (HK) Limited LIVE ATTENUATED VACCINE WITHOUT VIRULENCE FACTOR AND SUITABLE FOR COLD SUITABLE FOR MUCOSAL ADMINISTRATION
ES2923133T3 (es) 2017-08-04 2022-09-23 Hospital For Sick Children Plataforma de nanopartículas para el suministro de anticuerpos y vacunas
CN107353328A (zh) * 2017-08-23 2017-11-17 上海市动物疫病预防控制中心 一种重组的h9n2亚型禽流感病毒样颗粒及其制备方法和用途
CN110240634B (zh) * 2018-03-08 2022-09-06 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
CN108409842A (zh) * 2018-03-15 2018-08-17 山东省农业科学院畜牧兽医研究所 一种单克隆抗体及其制备方法
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
US11389523B2 (en) 2018-08-20 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
JP7662157B2 (ja) 2019-02-08 2025-04-15 ウィスコンシン アルムニ リサーチ ファンデイション ヒト化細胞系
WO2020223699A1 (en) 2019-05-01 2020-11-05 Wisconsin Alumni Research Foundation (Warf) Improved influenza virus replication for vaccine development
JP7627911B2 (ja) 2019-08-27 2025-02-07 ウィスコンシン アルムニ リサーチ ファンデイション 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
US11739303B2 (en) 2020-01-24 2023-08-29 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized NA
JP7672162B2 (ja) * 2020-03-24 2025-05-07 チョル アン，ビョン 幼い哺乳動物の粘膜関連伝染性疾病を予防または治療するための血清組成物の製造方法、前記方法によって製造された血清組成物及びその用途
KR102151962B1 (ko) * 2020-03-24 2020-09-04 안병철 어린 포유동물의 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
CN113461786B (zh) * 2020-03-30 2022-09-13 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用
AU2021262999A1 (en) 2020-05-01 2023-01-19 Sinocelltech Ltd. Method for improving immunogenicity of protein/peptide antigen
CN112342149A (zh) * 2020-11-12 2021-02-09 新疆畜牧科学院兽医研究所（新疆畜牧科学院动物临床医学研究中心） 一种禽流感病毒样颗粒组装表达系统及其应用
CN112979796A (zh) * 2021-04-27 2021-06-18 军事科学院军事医学研究院军事兽医研究所 马抗甲型h5n1虎源流感病毒免疫球蛋白和特异性免疫球蛋白及其精制方法
CN113862284B (zh) * 2021-09-13 2023-05-26 华南农业大学 一种编码重组禽流感病毒ha蛋白的基因、病毒样颗粒、疫苗及制备与应用
CN114262720B (zh) * 2021-12-27 2023-07-25 河南兴华生物技术有限公司 杆状病毒表达系统的信号肽及其应用
CN116286884A (zh) * 2023-02-22 2023-06-23 扬州大学 Ha蛋白糖基化修饰模式改变的禽流感病毒样颗粒及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4911928A (en) 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US6387373B1 (en) 1993-01-15 2002-05-14 Novavax, Inc. Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
US5629021A (en) 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
DK1294892T3 (da) * 2000-06-23 2008-01-28 Wyeth Corp Aggregering af vildtype- og kimære influenzaviruslignende partikler (VLP'er)
WO2003068993A1 (en) 2002-02-14 2003-08-21 Novavax, Inc. Method for isolation and purification of expressed gene products in vitro
US8592197B2 (en) * 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)

Also Published As

Publication number Publication date
RU2008119501A (ru) 2009-11-27
CA2625406C (en) 2016-08-09
TW200732476A (en) 2007-09-01
HK1121687A1 (en) 2009-04-30
AU2006304640B2 (en) 2012-10-11
WO2007047831A3 (en) 2007-07-19
JP2012157367A (ja) 2012-08-23
BRPI0617486A2 (pt) 2011-07-26
EP1937301A4 (en) 2009-06-24
KR20080081901A (ko) 2008-09-10
DK1937301T3 (en) 2015-07-20
TWI488968B (zh) 2015-06-21
JP5771558B2 (ja) 2015-09-02
AU2006304640A1 (en) 2007-04-26
JP2009511084A (ja) 2009-03-19
PT1937301E (pt) 2015-09-14
NZ567164A (en) 2012-06-29
CN103865892B (zh) 2017-04-12
JP2017189178A (ja) 2017-10-19
CN103865892A (zh) 2014-06-18
JP5714799B2 (ja) 2015-05-07
SG2014012868A (en) 2014-09-26
CN101325966A (zh) 2008-12-17
ES2543056T3 (es) 2015-08-14
IL190775A (en) 2016-04-21
SI1937301T1 (sl) 2015-08-31
HUE026136T2 (en) 2016-05-30
WO2007047831A2 (en) 2007-04-26
RU2483751C2 (ru) 2013-06-10
JP2015083018A (ja) 2015-04-30
CA2625406A1 (en) 2007-04-26
EP1937301A2 (en) 2008-07-02
IL190775A0 (en) 2008-11-03
KR101359723B1 (ko) 2014-02-05
JP2016135142A (ja) 2016-07-28
CN101325966B (zh) 2014-04-09
EP1937301B1 (en) 2015-04-22

Similar Documents

Publication Publication Date Title
SG2014012868A (en) Functional influenza virus like particles (vlps)
IL182817A0 (en) Defective influenza virus particles
EP2044198A4 (en) CHIMERIC INFLUENZA VIRUS TYPE PARTICLES
ZA200800505B (en) Modified influenza virus for monitoring and improving vaccine efficiency
IL183888A0 (en) Rescue of influenza virus
IL210215A0 (en) Influenza virus-like particles (vlps) comprising hemagglutinin
EP1888459A4 (en) SILICON NANOEPONGES PARTICLES
IL189329A0 (en) Vaccination against dengue virus infection
SG10201701988TA (en) Virus like particle purification
IL190906A0 (en) Influenza viruses able to infect canids, uses thereof
WO2008049974A8 (en) Peptide vaccine for influenza virus
WO2007051036A8 (en) Influenza combinatorial antigen vaccine
ZA200809056B (en) Influenza virus vaccine
EP1973837A4 (en) LIPID NANOPARTICLES
EP1885394A4 (en) PRODUCTION OF MULTIVALENT PARTICLES LIKE VIRUSES
IL186057A0 (en) RNAi-INDUCING AGENT FOR INFLUENZA VACCINE
GB0416487D0 (en) Modified virus
PT1942933E (pt) Vacinas contra a gripe canina
EP1871786A4 (en) PEPTIDE VACCINE AGAINST THE GRIPPEVIRUS
GB0610209D0 (en) Assay particles
ZA200703793B (en) Defective influenza virus particles
ZA200803883B (en) Chimaeric HIV-1 subtype C Gag-virus-like particles
GB2427113B (en) Virus deactivation unit
ZA200802176B (en) Vaccination against dengue virus infection
PL1802746T3 (pl) Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B